continu
emerg
spread
infecti
agent
great
concern
system
biolog
approach
infecti
diseas
research
advanc
understand
hostpathogen
relationship
facilit
develop
new
therapi
vaccin
molecular
character
infecti
sampl
outsid
appropri
biosafeti
contain
take
place
subsequ
pathogen
inactiv
herein
describ
modifi
folch
extract
use
chloroformmethanol
facilit
molecular
character
infecti
sampl
enabl
simultan
pathogen
inactiv
extract
protein
metabolit
lipid
subsequ
mass
spectrometrybas
multiom
measur
singlesampl
metabolit
protein
lipid
extract
mplex
method
result
complet
inactiv
clinic
import
bacteri
viral
pathogen
expos
lipid
membran
includ
yersinia
pesti
salmonella
typhimurium
campylobact
jejuni
pure
cultur
yersinia
pesti
campylobact
jejuni
west
nile
merscov
ebola
influenza
virus
infect
studi
addit
inactiv
increas
solvent
exposur
time
also
observ
pathogen
without
expos
lipid
membran
includ
communityassoci
methicillinresist
staphylococcu
aureu
clostridium
difficil
spore
veget
cell
adenoviru
type
overal
pipelin
inactiv
subsequ
proteom
metabolom
lipidom
analys
evalu
use
human
epitheli
lung
cell
line
infect
wildtyp
mutant
influenza
virus
therebi
demonstr
mplex
yield
biomateri
suffici
qualiti
subsequ
multiom
analys
base
experiment
result
believ
mplex
facilit
system
biolog
studi
infecti
sampl
enabl
simultan
pathogen
inactiv
multiom
measur
singl
specimen
high
success
pathogen
expos
lipid
membran
infecti
diseas
research
global
interest
sinc
emerg
spread
infecti
agent
repres
ongo
challeng
due
popul
growth
associ
increas
livestock
product
meet
food
demand
increas
urban
landus
chang
greater
travel
emerg
infecti
diseas
often
zoonot
transmit
human
anim
eg
middl
eastern
respiratori
syndrom
coronaviru
merscov
west
nile
viru
influenza
virus
ebola
recent
demonstr
ebola
viru
infect
diagnos
unit
state
eas
world
travel
increas
global
interdepend
ad
complex
contain
infecti
diseas
similarli
new
infecti
diseas
evolv
emerg
preexist
infecti
diseas
reemerg
new
genet
adapt
exampl
novel
antigen
distinct
subtyp
influenza
virus
recogn
neutral
antibodi
caus
pandem
outbreak
overus
antimicrobi
drug
decreas
complianc
vaccin
polici
led
develop
resist
pathogen
eg
drugresist
staphylococcu
campylobact
reemerg
diseas
previous
control
eg
pertussi
measl
addit
uncontrol
neglect
tropic
diseas
dengu
fever
west
nile
enceph
endem
develop
countri
emerg
unit
state
respons
global
threat
nation
institut
allergi
infecti
diseas
niaid
system
biolog
infecti
diseas
research
program
support
research
focus
hostpathogen
interact
character
use
combin
multiom
approach
dataset
integr
develop
valid
predict
model
infecti
diseas
initi
progress
outcom
infecti
diseas
research
use
system
biolog
approach
imper
understand
hostpathogen
relationship
allow
develop
new
therapi
vaccin
specif
proteom
metabolom
lipidom
measur
assist
unravel
hostpathogen
relationship
protein
major
effector
cellular
pathway
repres
dynam
express
inform
encod
within
genom
infect
metabolit
intermedi
product
cellular
pathway
repres
level
pharmaceut
exert
effect
addit
key
function
signal
pathway
energi
storag
structur
integr
cell
membran
lipid
also
function
hostpathogen
interact
immunomodul
sinc
act
first
line
recognit
host
cell
signal
pathogen
dock
invas
intracellular
traffick
howev
proteom
metabolom
lipidom
character
infecti
biolog
specimen
outsid
appropri
biosafeti
level
bsl
contain
laboratori
take
place
subsequ
pathogen
inactiv
nonenvelop
virus
adenovirus
norovirus
bacteri
spore
resist
disinfect
requir
altern
method
inactiv
pathogen
expos
lipid
membran
suscept
disinfect
includ
deterg
solvent
organ
solvent
render
mani
pathogen
noninfecti
solubil
disrupt
lipid
membran
envelop
inactiv
pathogen
organ
solvent
leverag
vaccin
develop
transfus
fluid
sanit
system
biolog
studi
pathogen
bacteria
virus
would
highli
effici
inactiv
pathogen
extract
molecular
compon
need
proteom
metabolom
lipidom
analys
singl
step
two
highli
cite
public
lipidbas
extract
method
folch
et
al
dyer
et
al
use
high
ratio
organ
solvent
sampl
eg
illustr
broad
util
techniqu
cell
tissu
extract
recent
variat
folch
techniqu
broader
util
extract
metabolit
protein
demonstr
modifi
folch
techniqu
use
chloroformmethanol
simultan
protein
metabolit
lipid
extract
subsequ
mass
spectrometri
ms
base
multiom
analys
also
result
concurr
pathogen
inactiv
specif
investig
metabolit
protein
lipid
extract
mplex
protocol
could
inactiv
divers
infecti
agent
expos
embed
lipid
bilay
includ
three
gramneg
bacteria
yersinia
pesti
salmonella
enterica
subspeci
enterica
serovar
typhimurium
campylobact
jejuni
gramposit
communityassoci
methicillinresist
staphylococcu
aureu
mrsa
isol
clostridium
difficil
strain
spore
veget
cell
four
rna
virus
also
test
mplex
could
inactiv
adenoviru
type
contain
outer
lipid
bilay
mplex
use
chloroform
methanol
water
induc
triphas
partit
sampl
metabolit
protein
lipid
fraction
metabolit
locat
upper
aqueou
layer
wherea
lipid
locat
lower
organ
layer
centrifug
protein
disc
situat
two
phase
fig
studi
mplex
subsequ
assess
pathogen
inactiv
perform
across
multipl
laboratori
laboratori
uniqu
expertis
experi
studi
pathogen
question
studi
present
manuscript
conduct
accord
appropri
biosafeti
guidelin
perform
bsl
contain
laboratori
univers
wisconsinmadison
ohio
state
univers
washington
state
univers
univers
north
carolina
chapel
hill
univers
texa
medic
branch
washington
univers
school
medicin
approv
use
center
diseas
control
prevent
us
depart
agricultur
abil
mplex
inactiv
pathogen
determin
compar
pathogen
presenc
abund
either
pretreat
posit
control
vs
mplextreat
sampl
typhimurium
c
jejuni
mrsa
c
difficil
spore
inactiv
experi
pretreat
mplextreat
replic
time
pesti
viral
inactiv
experi
replic
time
mplex
treatment
singl
sampl
use
assess
viral
activ
pretreat
posit
control
describ
basic
pathogen
inactiv
simultan
multiom
extract
protocol
method
cultur
bacteria
virus
establish
infect
vari
depend
model
pathogen
includ
relev
experiment
detail
descript
studi
supplement
materi
biosafeti
cabinet
bsc
remov
media
infect
cell
immedi
wash
cell
suitabl
buffer
author
recommend
buffer
use
quench
cell
metabol
solut
maintain
consist
methanol
ammonium
bicarbon
water
vortex
leav
sampl
ice
min
vortex
remov
aliquot
mix
solut
inactiv
assay
centrifug
remain
solut
g
min
remov
top
phase
fresh
tube
remov
bottom
phase
second
tube
leav
protein
disc
behind
rins
protein
disc
methanol
pellet
g
min
decant
methanol
solut
allow
pellet
dri
bsc
min
tube
remov
bsc
bsl
contain
laboratori
appropri
disinfect
either
store
dri
vacuo
safe
ship
metabolit
lipid
phase
store
bacteri
pathogen
viral
pathogen
assess
infect
studi
infect
host
cell
treat
mplex
inactiv
evalu
via
inocul
result
cell
lysat
fresh
cell
infect
studi
mplextreat
cell
lysat
dilut
retain
host
cell
viabil
undilut
sampl
induc
toxic
valid
inactiv
procedur
carri
sampl
dri
speedvac
rather
liquiddilut
extract
prior
dri
depict
figur
figur
mplex
method
extract
protein
metabolit
lipid
singl
sampl
msbase
multiom
profil
also
simultan
inactiv
number
clinic
import
bacteri
viral
pathogen
expos
lipid
membran
includ
pesti
typhimurium
c
jejuni
pure
cultur
pesti
c
jejuni
wnv
merscov
ebola
influenza
virus
infect
studi
near
complet
inactiv
observ
pathogen
without
expos
lipid
membran
includ
camrsa
c
difficil
spore
veget
cell
min
mplex
exposur
time
see
supplement
materi
tabl
detail
addit
demonstr
mplex
yield
biomateri
suffici
qualiti
subsequ
multiom
analys
figur
highlight
reproduc
proteom
metabolom
lipidom
data
human
epitheli
lung
cell
infect
either
wildtyp
tabl
figur
show
viral
peptid
ribosom
protein
metabolit
lipid
significantli
increas
infect
sampl
compar
match
mock
control
due
infect
durat
across
viral
strain
tabl
peptid
metabolit
lipid
statist
perform
compar
data
match
viru
mockinfect
control
use
analysi
varianc
anova
dunnett
multipl
test
correct
within
time
point
qualit
chang
via
gtest
bonferroni
multipl
test
correct
within
time
point
peptid
metabolit
lipid
pvalu
less
identifi
significantli
differ
tabl
top
figur
depict
viral
peptid
belong
viral
protein
hemagglutinin
ha
matrix
protein
neuraminidas
na
nucleoprotein
np
rna
polymeras
complex
pa
significantli
increas
gtest
observ
infect
sampl
earli
h
number
signific
peptid
increas
h
statist
analysi
proteom
data
also
found
signific
quantit
increas
rel
abund
ribosom
subunit
infect
durat
across
viral
strain
influenza
life
cycl
singlestrand
viral
rna
migrat
nucleu
copi
mrna
viral
rna
polymeras
complex
invad
virus
harbor
function
ribosom
virion
therefor
viral
mrna
hijack
host
cell
ribosom
use
sophist
mechan
enabl
select
translat
viral
mrna
free
fatti
acid
metabolit
myrist
acid
oleic
acid
significantli
increas
h
post
infect
across
viral
strain
fig
ceramid
cer
contain
stearic
acid
tetracosano
acid
significantli
increas
h
fm
h
likewis
cer
contain
stearic
acid
nervon
acid
significantli
increas
h
fm
h
fm
fig
previous
report
pathogen
avian
influenza
virus
decreas
express
lipid
metabol
gene
mutat
fm
strain
reduc
overal
pathogen
earli
hour
time
point
infect
wildtyp
strain
show
increas
viral
peptid
compar
fm
mutant
fig
correspondingli
h
time
point
ribosom
express
significantli
increas
viru
late
hour
time
point
signific
ribosom
express
increas
compar
fm
base
result
believ
mplex
benefit
facilit
system
biolog
studi
infecti
sampl
enabl
pathogen
inactiv
multiom
measur
singl
specimen
high
success
pathogen
expos
lipid
membran
figur
illustr
bacteri
viral
pathogen
studi
contain
expos
embed
lipid
membran
membran
denot
orang
color
bacteri
pathogen
character
studi
pesti
typhimurium
c
jejuni
gramneg
bacteria
camrsa
gramposit
bacterium
c
difficil
spore
form
gramposit
bacterium
fig
expos
wall
gramposit
bacteria
higher
peptidoglycan
pg
lower
lipid
content
gramneg
bacteria
bacteri
classif
base
gram
stain
method
differenti
bacteria
chemic
physic
properti
cell
wall
detect
pg
present
thick
layer
gramposit
bacteria
inner
membran
dormant
spore
compos
bilay
immobil
phospholipid
similar
phospholipid
composit
grow
bacteria
exhibit
low
permeabl
small
molecul
includ
water
inner
membran
surround
spore
core
contain
genom
basic
spore
architectur
conserv
outsid
inner
membran
layer
pg
known
germ
cell
wall
encircl
thick
layer
modifi
form
pg
cortex
essenti
acquisit
mainten
heat
resist
cortex
surround
outer
membran
deriv
mother
cell
essenti
spore
format
confer
resist
properti
proteinac
coat
surround
outer
membran
c
difficil
spore
coat
enclos
within
structur
known
exosporium
partial
inactiv
result
present
camrsa
experiment
replic
still
retain
small
level
bacteri
activ
c
difficil
spore
reveal
mplex
dissolv
protect
pg
layer
encircl
lipid
bilay
long
enough
exposur
time
could
lead
complet
pathogen
inactiv
level
inactiv
c
difficil
spore
due
mplex
treatment
exposur
time
min
fig
addit
two
replic
experi
camrsa
experi
lower
initi
bacteri
concentr
pretreat
show
complet
inactiv
due
mplex
wnv
merscov
ebola
influenza
viru
contain
lipid
bilay
envelop
fig
wnv
virion
acquir
lipid
envelop
bud
endoplasm
reticulum
host
cell
coronavirus
merscov
acquir
membran
ergolgi
intermedi
compart
ergic
use
normal
cellular
process
leav
cell
ebola
influenza
virion
acquir
lipid
envelop
bud
host
plasma
membran
often
lipid
raft
microdomain
enrich
sphingomyelin
cholesterol
viru
complet
inactiv
mplex
nonenvelop
viru
therefor
contain
lipid
membran
fig
conclus
show
mplex
complet
inactiv
pathogen
expos
lipid
membran
envelop
virus
gramneg
bacteria
therebi
facilit
multiom
measur
singl
specimen
clinic
import
pathogen
studi
pathogen
intern
protect
lipid
membran
gramposit
bacteria
bacteri
spore
still
show
signific
decreas
activ
reduct
number
viabl
microorgan
mplex
treatment
relat
mplex
solut
exposur
time
pretreat
pathogen
level
even
viru
without
lipid
membran
show
decreas
activ
mplex
exposur
presum
sinc
nonenvelop
virus
still
suscept
organ
solvent
particular
chcl
due
denatur
protein
solvent
sensit
summari
believ
mplex
method
concurr
pathogen
inactiv
extract
sampl
multiom
profil
broadli
applic
sampl
contain
clinic
import
bacteri
viral
pathogen
expos
lipid
membran
sinc
molecular
character
infecti
sampl
outsid
appropri
biosafeti
contain
take
place
subsequ
complet
pathogen
inactiv
note
biosafeti
reason
protocol
evalu
investig
laboratori
efficaci
pathogen
inactiv
prior
implement
particularli
pathogen
evalu
studi
refer
web
version
pubm
central
supplementari
materi
